Dace Zavadska

Riga, RIX, Latvia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 83 publications

Immunogenicity and safety of an investigational quadrivalent measles, mumps, rubella, and varicella vaccine in children aged 4-6 years: A phase II, randomized, multi-country trial.

Immunogenicity and safety of an investigational quadrivalent measles, mumps, rubella, and varicella vaccine in children aged 4-6 years: A phase II, randomized, multi-country trial.

Journal: Human vaccines & immunotherapeutics
Published: May 26, 2026

Vaccination policies for healthcare personnel in Europe, 2026.

Vaccination policies for healthcare personnel in Europe, 2026.

Journal: Vaccine
Published: May 11, 2026

Long-Term Outcomes in Adult Patients with Tick-Borne Encephalitis in Latvia.

Long-Term Outcomes in Adult Patients with Tick-Borne Encephalitis in Latvia.

Journal: Pathogens (Basel, Switzerland)
Published: May 03, 2026

The Ongoing Challenge of Pertussis in Eastern and Northern Europe: Recommendations from the Global Pertussis Initiative.

The Ongoing Challenge of Pertussis in Eastern and Northern Europe: Recommendations from the Global Pertussis Initiative.

Journal: Infectious diseases and therapy
Published: November 24, 2025

Immunity to Streptococcus pyogenes and Common Respiratory Viruses at Age 0 to 4 Years After COVID-19 Restrictions.

Immunity to Streptococcus pyogenes and Common Respiratory Viruses at Age 0 to 4 Years After COVID-19 Restrictions.

Journal: JAMA network open
Published: October 15, 2025

Effectiveness, immunogenicity and safety of human papillomavirus vaccination in non-HIV immunocompromised individuals: a systematic review.

Effectiveness, immunogenicity and safety of human papillomavirus vaccination in non-HIV immunocompromised individuals: a systematic review.

Journal: EClinicalMedicine
Published: October 13, 2025

Seroprevalence of Tick-Borne Encephalitis Virus in Latvia Using Standard and Subtype-Specific NS1-Based ELISA Assays.

Seroprevalence of Tick-Borne Encephalitis Virus in Latvia Using Standard and Subtype-Specific NS1-Based ELISA Assays.

Journal: Pathogens (Basel, Switzerland)
Published: September 22, 2025

Human papillomavirus (HPV) vaccination in women with conisation.

Human papillomavirus (HPV) vaccination in women with conisation.

Journal: The Cochrane database of systematic reviews
Published: September 08, 2025

Distribution and Genotypic Landscape of Tick-Borne Encephalitis Virus in Ticks from Latvia from 2019 to 2023.

Distribution and Genotypic Landscape of Tick-Borne Encephalitis Virus in Ticks from Latvia from 2019 to 2023.

Journal: Pathogens (Basel, Switzerland)
Published: August 23, 2025

Hybrid, infection- and vaccination-induced protection against laboratory- confirmed SARS-CoV-2 infection in a European multi-centre prospective cohort of healthcare workers, 2021-2024.

Hybrid, infection- and vaccination-induced protection against laboratory- confirmed SARS-CoV-2 infection in a European multi-centre prospective cohort of healthcare workers, 2021-2024.

Journal: BMC medicine
Published: August 04, 2025

Genome-wide association study identifies ABCG1 as a susceptibility locus for tick-borne encephalitis.

Genome-wide association study identifies ABCG1 as a susceptibility locus for tick-borne encephalitis.

Journal: iScience
Published: July 10, 2025

Tick-borne encephalitis vaccine effectiveness and public health impact in the Baltic countries of Estonia, Latvia, and Lithuania, 2019-2023.

Tick-borne encephalitis vaccine effectiveness and public health impact in the Baltic countries of Estonia, Latvia, and Lithuania, 2019-2023.

Journal: IJID regions
Published: July 08, 2025
Showing 1-12 of 83

Last Updated: 09/26/2026